|HIV+ patient cohorts
||Criteria for cohort inclusion
|HIV-infected adult cohort (CoRIS):
Includes patients over the age of 13 with a confirmed diagnosis of HIV infection that have not received prior antiretroviral treatment and are being seen for the first time in the participating centre
|Rapid progressors cohort
||Includes patients whose CD4+ T-cell levels have fallen below 350 lymphocytes or patients who are diagnosed with AIDS before the end of the third year after their documented seroconversion date (and beyond the first 3 months) and with a window of fewer than 2 years between the last negative and first positive test, always in the absence of ART.
|Long Term Non-Progressors cohort (LTNP-RIS)
||includes patients who have had > 500/μL CD4+ T-cell count and <10,000 HIV-RNA copies/ml viral load for over 10 years, in the absence of ART.
|HIV Controller cohort (EC-RIS)
|| ART-naive patients who have been HIV+ for more than 12 months with at least two viral load determinations during such period. Elite controllers: <50 HIV-RNA copies/ml Viral controllers: individuals within this range: >50 – <2000 copies/ml.
|Acute/recent infection cohort (PHI-RIS)
||Acute infection: Patients within the first three months after documented seroconversion date
Recent infection: Patients within the first six months after documented seroconversion date
|Vertical transmission cohort (CoRISpe)
||HIV patients infected by vertical transmission
|Hepatitis C (HCV) and HIV Co-infection cohort (HIV-HCV coinfection cohort)
||HIV-HCV coinfected patients